SAPA-NE 24th Annual Conference: New Era and Unprecedented Opportunities for Developing Novel Therapies

Saturday, Sep 24, 2022, 9 AM – 4 PM EDT (美东时间)

Free Zoom Webinar [Agenda] [Brochure]

The event features presentations and panel discussions presented by distinguished speakers/panelists in academic or industry.

Topics include:

•  Future of Drug Discovery and Development 
• New Modality Platforms and Frontiers 
• Enabling Technology Advancement and Applications 
• Targeted Drug Delivery 

[Keynote Speakers]

Future of Drug Discovery and Development 

• Dr. Hong Shen, SVP, Roche China, The journey of the China Innovation Center of Roche (CICoR)
• Dr. Tommy Vaughan, Professor, Columbia University, MRI for the World

New Modality Platforms and Frontiers 

• Dr. Leo Qian, Co-Founder and VP, Entrada Therapeutics, Endosomal Escape Vehicle (EEV) Platform to Enhance the Functional Delivery of Oligonucleotides
• Mr. Saket Agarwal, Scientist, Alnylam Pharmaceuticals, Recent Advances in Delivery of RNAi Therapeutics to the CNS
• Dr. Guoqiang Wang, VP, Chemistry at Ranok Therapeutic, Chaperone-mediated Protein Degradation (CHAMP™): A Tumor-targeted Protein Degrader Technology
• Dr. Shuling Guo, VP, Ionis Pharmaceuticals, RNA Therapeutics--A Versatile Drug Discovery Platform

Enabling Technology Advancement and Applications 

• Dr. James Jin, VP, Biocytogen Boston Corp, Gene engineered mouse models (GEMMs) in drug discovery
• Chris Moore and Zach Houston, Perkin Elmer, Visualizing the effects of therapy with Vega and IVIS preclinical imaging platforms
• Dr. Santi Chen, Associate Director, GemPharmatech, Supporting Preclinical Research and Drug Development with Cutting-Edge GEMMs and Services

Targeted Drug Delivery 

• Dr. Qiaobing Xu, CEO, Hopewell Therapeutics/Professor, Tufts University, Synthetic Biodegradable Lipid Nanoparticles for Gene Therapy and Gene Editing
• Dr. Steve Kates, VP, Regulatory Affairs, Dicerna, GalXC™ and GalXC-Plus™ RNAi Technologies: From Bench to Clinic

Career Development Panel Discussion

• Dr. Huijuan Li, VP, Moderna & Panelists from Moderna, BMS and Beam Therapeutics, Successful Career in Bio-Pharmaceutical Industry

(Note: All sales are final and NO refund shall be issued.)